Magnesia bisurata aromatic - counteracts the acidity of the stomach 80 tablets

Product Description

Magnesia Bisurata Aromatic: Lozenges

Active ingredients

Each lozenge contains: Active ingredients: Magnesium Carbonate 71.0 mg, Sodium bicarbonate 64.2 mg, Calcium carbonate 525.0 mg.

Excipients

Sodium saccharin, Sucrose, Corn starch, Calcium stearate, Peppermint essential oil.

Therapeutic indications

Symptomatic treatment of upper digestive tract disorders characterised by hyperacidity.

Contraindications

Hypersensitivity to the active substances or to any of the excipients. Renal insufficiency. Do not administer simultaneously with Tetracyclines (see Section 4.5). Do not administer other drugs within 1 or 2 hours of using the product (see Section 4.5). Administration of the medicine in pediatric age is not recommended.

Dosage

One lozenge to dissolve slowly in the mouth after meals and whenever pain is felt. If necessary, repeat after a quarter of an hour. DO NOT EXCEED THE RECOMMENDED DOSES. Use only for short periods of treatment. Patients with renal insufficiency: The reduced ability to eliminate urine and the exogenous saline supplement provided by antacids can cause potentially severe electrolyte imbalances. Treatment with magnesium and calcium salts requires periodic checks of magnesium and calcium levels.

Warnings and precautions

Plasma magnesium levels tend to increase in patients with severe renal insufficiency. In these patients, prolonged exposure to high doses of magnesium may lead to encephalopathy or worsening of dialysis-induced osteomalacia. Caution should generally be exercised in patients with impaired renal function. Plasma calcium and magnesium levels should be monitored regularly in these patients. If following a low-sodium diet, it should be noted that the product contains sodium salts. The product contains sucrose; this should be taken into account in patients with diabetes. Patients with rare hereditary problems of fructose intolerance, glucose malabsorption, galactose malabsorption, sucrase insufficiency, and isomaltase insufficiency should not take this medicine.

Interactions

Please note that antacids can, through various mechanisms, interfere with the oral administration of other drugs. In particular, the concomitant administration of tetracyclines can result in insoluble complexes, reducing the absorption of these antibiotics. However, it is advisable not to administer other drugs within 1 or 2 hours of using the product.
Combinations to avoid:
– tetracyclines: formation of insoluble complexes with reduction of the absorption and activity of these antibiotics.
Combination not recommended:
– quinidine: increase in plasma levels of quinidine and risk of overdose due to decreased excretion.
Combinations requiring precautions for use:
– indomethacin, phosphorus, dexamethasone, digitalis, iron salts, nitrofurantoin, lincomycin.

Undesirable effects

Based on available bibliographic data, no side effects related to the specialty are known.

Pregnancy and breastfeeding

Although no adverse reactions are known, the product should be used under direct medical supervision in pregnant and breastfeeding women.